Nanoparticles based on polyferylic and polygentisic acids as new carriers of anticancer drugs

Author:

Smirnov I. V.1,Lisov A. V.2,Kazakov A. S.3,Zvonarev A. N.2,Suzina N. E.2,Zemskova M. Y.2

Affiliation:

1. Skolkovo Institute of Science and Technology

2. G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms, Russian Academy of Sciences

3. Institute of Biological Instrumentation, Russian Academy of Sciences

Abstract

Lignin polymers and their derivatives are actively used in various fields of biomedicine to create biocompatible materials, as medications, and to form nanoparticles. However, natural polymeric compounds derived from plant materials or monomers are defined as a mixture of compounds having a high heterogeneity in chemical structure, which greatly complicates the determination of their biological activity. This paper describes a new method of controlled synthesis using the enzyme laccase, which can be applied to obtain polymers with a specific structure. Based on enzymatically synthesized lignin-like polymers from ferulic and gentisiс phenolic monomers, nanoparticles with stable properties under physiological conditions were formed. The nanoparticles can differ in morphology from globular to fibrillar structures, depending on monomers used in the enzymatic reaction and the method of their formation. Nanoparticles obtained from lignin-like polymers of ferulic and gentisic acids can be loaded with low molecular weight hydrophobic compounds, including the anticancer drug doxorubicin. It has been shown that polyferulic nanoparticles are actively penetrate in tumor cells growing both in a monolayer culture and as part of spheroids, and, compared with a free compound, doxorubicin in the composition of nanoparticles has a greater cytotoxic effect on breast cancer cells. These data indicate the possibility of effective use of these carriers as passive targeted drug delivery in the treatment of tumors.

Publisher

The Russian Academy of Sciences

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3